Schrodinger
SDGR on Nasdaq. Schrödinger sells molecular discovery software and drug research services to pharmaceutical and industrial companies. Market value $1.1bn.
Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.
Should I look at this?
Not a fit for our list right now
Why it could be worth it
See Health care stocks that passed both tests
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $-6.14 of spare cash in the past 12 months. A savings account pays about $4.
The filings do not give us enough to work this out.
Each dollar kept in the business earns -36 cents a year. Above 10 is good.
Quality score: 44 of 100. Price score: 0 of 100. Our list needs 70 on quality and 60 on price.
$28.90 a share, 164% above its 1-year low
Over the past year the price has ranged from $10.94 to $33.78.
Pays no dividend
Prices from Tuesday’s close (6 October).
Five years of cash, in billions
Spare cash swings from quarter to quarter here: a shortfall of $130 million in the past 12 months, $12 million in the year to December 2025.
| Revenue | |||||
| Revenue | $138m | $181m | $217m | $208m | $256m |
| Operating margin | |||||
| Operating margin | -80.8% | -81.1% | -81.9% | -100.8% | -65.2% |
| Debt to equity | |||||
| Debt to equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares outstanding | |||||
| Shares outstanding | 0.06bn | 0.06bn | 0.06bn | 0.07bn | 0.07bn |
Health checks
- Free cash flow positive1 of 5 years
- Accounting looks honest (Beneish)Nothing unusual
- Financial strength (Piotroski)3 of 8 checks we could run
- Profit backed by cash (accruals)No
- Debt0.00× equity
- Revenue growth, five yearsStrong, 18.8% a year
- Buying back its own sharesNo, 19% more shares since 2021
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $59 million last quarter, up 8% on a year ago.
- Profit: $6 million, after a loss of $43 million a year ago.
- It loses 59 cents on each $1 of sales, compared with 81 cents a year earlier.
- Over the past 12 months it spent $130 million more cash than it brought in. A year earlier it had $24 million spare.
- 3% more shares than a year ago. Each share owns a bit less of the company.
- It has $288 million more cash than debt, up from $220 million a year ago.
- Sales grew on a year ago in 2 of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| September 2024 | $35m |
| December 2024 | $88m |
| March 2025 | $60m |
| June 2025 | $55m |
| September 2025 | $54m |
| December 2025 | $87m |
| March 2026 | $59m |
| June 2026 | $59m |
| Quarter to | Amount |
|---|---|
| September 2024 | -$38m |
| December 2024 | -$40m |
| March 2025 | -$60m |
| June 2025 | -$43m |
| September 2025 | -$33m |
| December 2025 | $33m |
| March 2026 | -$60m |
| June 2026 | $6m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 25 February 2026
- Next quarterly (estimated, 10-Q)
- 4 November 2026
Who owns it
1 long-term investor we follow owns it, down from 2 last quarter. 231 funds in all.
- Royce & AssociatesChuck Royce
- Value
- $471,396
- Share of fund
- <0.1%
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| Royce & AssociatesChuck Royce | $471,396 | <0.1% |
Sold out this quarter
Largest holders overall
- BlackRock$171mAdded
- Gates Foundation Trust$113m
- Rubric Capital Management LP$104mAdded
- Vanguard Portfolio Management$62m
- Sumitomo Mitsui Trust Group$44mCut
- Amova Asset Management Americas$44mCut
- Vanguard Capital Management$44mAdded
- State Street$37mAdded
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS$36mCut
- ARK Investment Management$35mAdded
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
5 investors own more than 5%.
- BlackRock, Inc.Passive investor12.7%Since 30 June 2025
- Rubric Capital Management LPPassive investorat least 9.3%+2.8 pts(filed with 1 related holder)Since 31 March 2026
- Vanguard Portfolio ManagementPassive investor6.0%Since 31 March 2026
- Nikko Asset Management Co., Ltd.Passive investor5.5%Since 31 December 2024
- Sumitomo Mitsui Trust Group, Inc.Passive investorat least 4.9%−2.2 pts(filed with 1 related holder)Since 31 March 2026
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
BlackRock, Inc. Passive investor | 12.7% | 30 June 2025 | |
Rubric Capital Management LP Passive investor | at least 9.3%+2.8 pts (filed with 1 related holder) | 31 March 2026 | |
Vanguard Portfolio Management Passive investor | 6.0% | 31 March 2026 | |
Nikko Asset Management Co., Ltd. Passive investor | 5.5% | 31 December 2024 | |
Sumitomo Mitsui Trust Group, Inc. Passive investor | at least 4.9%−2.2 pts (filed with 1 related holder) | 31 March 2026 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 8 sold $2m, $2m of it under preset trading plans.
- Akinsanya KarenSee RemarksSoldunder a preset trading plan
- Date
- 17 September 2026
- Shares
- 31,599
- Price
- $29.37
- Value
- $927,970
- Jain RachitEVP & CFOSoldunder a preset trading plan
- Date
- 16 July 2026
- Shares
- 875
- Price
- $15.60
- Value
- $13,647
- Farid RamyPresident & CEO, DirectorSoldunder a preset trading plan
- Date
- 17 April 2026
- Shares
- 43,000
- Price
- $12.21
- Value
- $525,030
- Jain RachitEVP & CFOSoldunder a preset trading plan
- Date
- 16 April 2026
- Shares
- 844
- Price
- $12.75
- Value
- $10,761
- Farid RamyPresident & CEO, DirectorSoldunder a preset trading plan
- Date
- 16 April 2026
- Shares
- 43,000
- Price
- $12.33
- Value
- $530,190
- Herman JennyCAOSoldunder a preset trading plan
- Date
- 6 March 2026
- Shares
- 608
- Price
- $12.84
- Value
- $7,807
- Jain RachitEVP & CFOSoldunder a preset trading plan
- Date
- 5 March 2026
- Shares
- 1,631
- Price
- $12.90
- Value
- $21,040
- Herman JennyCAOSoldunder a preset trading plan
- Date
- 5 March 2026
- Shares
- 775
- Price
- $12.85
- Value
- $9,959
- Tran YvonneEVP, CLO & CPOSoldunder a preset trading plan
- Date
- 5 March 2026
- Shares
- 1,094
- Price
- $12.90
- Value
- $14,113
- Lorton Kenneth PatrickEVP, CTO & COO, SoftwareSoldunder a preset trading plan
- Date
- 5 March 2026
- Shares
- 1,222
- Price
- $12.90
- Value
- $15,764
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 17 September 2026 | Akinsanya Karen See Remarks | Sold under a preset trading plan | 31,599 | $29.37 | $927,970 |
| 16 July 2026 | Jain Rachit EVP & CFO | Sold under a preset trading plan | 875 | $15.60 | $13,647 |
| 17 April 2026 | Farid Ramy President & CEO, Director | Sold under a preset trading plan | 43,000 | $12.21 | $525,030 |
| 16 April 2026 | Jain Rachit EVP & CFO | Sold under a preset trading plan | 844 | $12.75 | $10,761 |
| 16 April 2026 | Farid Ramy President & CEO, Director | Sold under a preset trading plan | 43,000 | $12.33 | $530,190 |
| 6 March 2026 | Herman Jenny CAO | Sold under a preset trading plan | 608 | $12.84 | $7,807 |
| 5 March 2026 | Jain Rachit EVP & CFO | Sold under a preset trading plan | 1,631 | $12.90 | $21,040 |
| 5 March 2026 | Herman Jenny CAO | Sold under a preset trading plan | 775 | $12.85 | $9,959 |
| 5 March 2026 | Tran Yvonne EVP, CLO & CPO | Sold under a preset trading plan | 1,094 | $12.90 | $14,113 |
| 5 March 2026 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Sold under a preset trading plan | 1,222 | $12.90 | $15,764 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.